- Home
- OSS vs SRZN Comparison
OSS vs SRZN Comparison
Compare OSS & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSS | SRZN |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Computer Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.7M | 271.6M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OSS | SRZN |
|---|---|---|
| Price | $9.07 | $16.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $10.00 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 660.7K | 163.3K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,027,382.00 | $3,477,000.00 |
| Revenue This Year | $22.19 | $75.35 |
| Revenue Next Year | $20.67 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 34.46 | N/A |
| 52 Week Low | $4.17 | $11.35 |
| 52 Week High | $20.88 | $35.00 |
Technical Indicators
Market Signals| Indicator | OSS | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 30.27 | 24.38 |
| Support Level | $8.56 | $17.44 |
| Resistance Level | $14.36 | $23.55 |
| Average True Range (ATR) | 0.45 | 1.35 |
| MACD | -0.08 | -0.58 |
| Stochastic Oscillator | 7.71 | 4.34 |
Price Performance
Historical ComparisonAbout OSS One Stop Systems Inc.
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).